Shandong Pharmaceutical Glass operates within the Pressed and blown glass sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shandong Pharmaceutical Glass with three other
companies in this sector in China:
Jiangsu Changhai Composite Materials Co Ltd
sales of 1.52 billion Chinese Renmimbi [US$221.63 million]
of which 76%
was Glass Fibre),
Jiangsu Jiuding New Material Company Limited
(687.70 million Chinese Renmimbi [US$100.56 million]
of which 95%
was Industry), and
Jiangsu Xiuqiang Glasswork Co Ltd
(1.02 billion Chinese Renmimbi [US$149.15 million]
of which 100%
was Glass Further Processing).
During the year ended December of 2015, sales at
Shandong Pharmaceutical Glass were 1.72 billion Chinese Renmimbi (US$251.86 million).
a very small
increase of 1.9%
versus 2014, when the company's sales were 1.69 billion Chinese Renmimbi.
This was the fourth straight year of sales growth at Shandong Pharmaceutical Glass.
Sales of Manufacturing saw an increase
2.9% in 2015, from
1.59 billion Chinese Renmimbi to 1.63 billion Chinese Renmimbi.
Not all segments of Shandong Pharmaceutical Glass experienced an increase in sales in 2015:
sales of Other Operation fell 20.8% to 25.64 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).
Shandong Pharmaceutical Glass also experienced decreases in sales in
Trading (down 9.4% to 66.32 million Chinese Renmimbi)